8.33
price up icon0.00%   0.00
after-market Dopo l'orario di chiusura: 8.30 -0.03 -0.36%
loading
Precedente Chiudi:
$8.33
Aprire:
$8.28
Volume 24 ore:
306.35K
Relative Volume:
0.82
Capitalizzazione di mercato:
$491.59M
Reddito:
-
Utile/perdita netta:
$-153.16M
Rapporto P/E:
-2.2575
EPS:
-3.69
Flusso di cassa netto:
$-134.48M
1 W Prestazione:
+7.21%
1M Prestazione:
+6.25%
6M Prestazione:
-21.04%
1 anno Prestazione:
-58.99%
Intervallo 1D:
Value
$8.09
$8.39
Intervallo di 1 settimana:
Value
$7.42
$8.39
Portata 52W:
Value
$6.85
$20.96

Cullinan Therapeutics Inc Stock (CGEM) Company Profile

Name
Nome
Cullinan Therapeutics Inc
Name
Telefono
617-410-4650
Name
Indirizzo
ONE MAIN STREET, CAMBRIDGE
Name
Dipendente
111
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
CGEM's Discussions on Twitter

Confronta CGEM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CGEM
Cullinan Therapeutics Inc
8.33 478.61M 0 -153.16M -134.48M -3.69
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-11 Ripresa Stifel Buy
2024-10-24 Iniziato UBS Buy
2024-05-01 Iniziato Stifel Buy
2024-04-15 Iniziato William Blair Outperform
2024-02-15 Iniziato Wedbush Outperform
2023-06-15 Iniziato TD Cowen Outperform
2022-11-21 Iniziato BTIG Research Buy
2021-04-27 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2021-02-02 Iniziato Evercore ISI Outperform
2021-02-02 Iniziato Morgan Stanley Equal-Weight
2021-02-02 Iniziato SVB Leerink Outperform
2021-02-01 Iniziato H.C. Wainwright Buy
Mostra tutto

Cullinan Therapeutics Inc Borsa (CGEM) Ultime notizie

pulisher
Jul 23, 2025

What drives Cullinan Therapeutics Inc. stock priceAccelerated investment success - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Cullinan Therapeutics Inc. a good long term investmentUnbelievable profit margins - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Breakthrough Lung Cancer Treatment: Zipalertinib Trial Results Reveal New Hope for Hard-to-Treat EGFR Mutations - Stock Titan

Jul 22, 2025
pulisher
Jul 19, 2025

What analysts say about Cullinan Therapeutics Inc. stockExplosive market performance - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Cullinan Therapeutics Inc. Stock Analysis and ForecastExceptional stock performance - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 15, 2025

Zipalertinib's NDA Submission: Can Cullinan Therapeutics Finally Cash In on Its Breakthrough? - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Cullinan Therapeutics: Betting On Zipalertinib NDA Catalyst - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

How Cullinan Therapeutics Inc. stock performs during market volatilityChart Breakout Alert - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Cullinan Therapeutics Inc. stock attracts strong analyst attentionBalanced Risk Reward Portfolio - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Cullinan Therapeutics Inc. stock price move sharplyFree Stock Market Expert Consultation - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Disc Medicine Appoints Nadim Ahmed To Board - citybiz

Jul 14, 2025
pulisher
Jul 14, 2025

Disc Medicine Appoints Nadim Ahmed to its Board of Directors - The Manila Times

Jul 14, 2025
pulisher
Jul 10, 2025

We're Keeping An Eye On Cullinan Therapeutics' (NASDAQ:CGEM) Cash Burn Rate - Yahoo Finance

Jul 10, 2025
pulisher
Jul 09, 2025

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Jul 09, 2025
pulisher
Jul 03, 2025

Cullinan Oncology stock rating reiterated at Buy by Clear Street - Investing.com Australia

Jul 03, 2025
pulisher
Jun 30, 2025

Cullinan Therapeutics, Inc.(NasdaqGS:CGEM) dropped from Russell Microcap Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 21, 2025

Assenagon Asset Management S.A. Cuts Stock Position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - Defense World

Jun 21, 2025
pulisher
Jun 20, 2025

Asia Deal Watch: SunRock, Escugen Collaborate On CCR9-Targeted ADC - insights.citeline.com

Jun 20, 2025
pulisher
Jun 17, 2025

Cullinan deals $712M to test Genrix bispecific TCE in autoimmune - BioWorld MedTech

Jun 17, 2025
pulisher
Jun 17, 2025

Analysts Set Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Target Price at $30.00 - Defense World

Jun 17, 2025
pulisher
Jun 12, 2025

Cullinan Management Holds Annual Stockholders Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Another BiTE in autoimmune: Cullinan deals $712M for Genrix asset - BioWorld MedTech

Jun 12, 2025
pulisher
Jun 12, 2025

California State Teachers Retirement System Lowers Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Cullinan Therapeutics (NASDAQ:CGEM) Now Covered by Analysts at Stifel Nicolaus - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Stifel Reinstates Cullinan Therapeutics (CGEM) with Buy Rating a - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Stifel Reinstates Cullinan Therapeutics (CGEM) with Buy Rating and $22 Price Target | CGEM Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Stifel Recommends Buy Rating for Cullinan Therapeutics (CGEM) | CGEM Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 10, 2025

Two Sigma Investments LP Has $514,000 Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 10, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Sells 11,673 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

The week in pharma: action, reaction and insight – week to June 6 - The Pharma Letter

Jun 08, 2025
pulisher
Jun 07, 2025

Two Sigma Advisers LP Grows Stake in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Cullinan Therapeutics Licenses Rights to Velinotamig from Genrix Bio - Contract Pharma

Jun 05, 2025
pulisher
Jun 05, 2025

Cullinan Therapeutics Stock Slides After-Hours Despite $692M Autoimmune Drug Pact With Genrix By Stocktwits - Investing.com India

Jun 05, 2025

Cullinan Therapeutics Inc Azioni (CGEM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):